Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.75 USD | 0.00% | +8.70% | -14.38% |
Apr. 30 | Sector Update: Health Care Stocks Gain in Afternoon Trading | MT |
Apr. 30 | Eton Pharmaceuticals Submits New Drug Application to FDA For ET-400 | MT |
Financials (USD)
Sales 2024 * | 41.43M | Sales 2025 * | - | Capitalization | 96.33M |
---|---|---|---|---|---|
Net income 2024 * | 1M | Net income 2025 * | - | EV / Sales 2024 * | 2.33 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
53.6
x | P/E ratio 2025 * |
-
| Employees | 30 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.03% |
Latest transcript on Eton Pharmaceuticals, Inc.
1 day | +1.90% | ||
1 week | +20.19% | ||
Current month | +7.14% | ||
1 month | +1.90% | ||
3 months | -16.48% | ||
6 months | -15.54% | ||
Current year | -14.38% |
Managers | Title | Age | Since |
---|---|---|---|
Sean Brynjelsen
CEO | Chief Executive Officer | 52 | 17-05-31 |
James Gruber
DFI | Director of Finance/CFO | 52 | 22-04-10 |
Lisa M. Wilson
IRC | Investor Relations Contact | 59 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 17-05-31 | |
Paul Maier
BRD | Director/Board Member | 76 | 17-09-13 |
Norbert Riedel
CHM | Chairman | 66 | 17-09-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 3.75 | 0.00% | 60 759 |
24-05-02 | 3.75 | +1.90% | 69,162 |
24-05-01 | 3.68 | +5.14% | 18,430 |
24-04-30 | 3.5 | -0.57% | 36,653 |
24-04-29 | 3.52 | +2.03% | 82,744 |
Delayed Quote Nasdaq, May 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.38% | 96.33M | |
+6.59% | 69.91B | |
+12.55% | 9.24B | |
-12.75% | 5.05B | |
+42.38% | 4.47B | |
+5.23% | 3.92B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B | |
+4.60% | 1.66B |
- Stock Market
- Equities
- ETON Stock